Register for free to listen to this article
Listen with Speechify
0:00
1:00
CyBio
 
CyBi-SELMA is a semi-automatic pipettor that is fast,precise and robust. With 96 disposable tips, all 96- and 384-well microplateformats can be filled in seconds. Contrary to manual pipetting, sample transfererrors and missed wells are a thing of the past. All aspirate and dispensesteps are executed by the CyBio technology, which has been deployed inhigh-throughput screening very successfully for more than 15 years withguaranteed reproducible results. CyBi-SELMA is easy to use via a modern touchscreen. Adjustments such as dispense height, volume and pipetting speed arememorized, retrievable and changeable for regular use anytime. Automatic tiptightening avoids laborious adjustments, and preloaded tip trays guaranteerapid execution within seconds. Custom-racked tip magazines enable the omissionof individual columns and thus, give the user more options to create dispensepatterns specific to their assay requirements. Its compact dimensions allow itto fit on the lab bench easily as well as in any laminar flow box withoutdisrupting the air handling.
 
CyBio

+49-3641-351 0
 

Related Topics

Published In

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Gold circles with attached purple corkscrew shapes represent gold nanoparticles against a black background.

Driving gene therapy with nonviral vectors 

Learn why nonviral vectors are on the rise in gene therapy development.
A 3D digital illustration of a viral spike protein on a cell surface, surrounded by colorful, floating antibodies in the background

Milestone: Leapfrogging to quantitative, high throughput protein detection and analysis

Researchers continuously push the boundaries of what’s possible with protein analysis tools.
Blue cancer cells attached to a cellular surface against a bright blue background in a 3D rendering of a cancer infection.

Advancing immuno-oncology research with cellular assays

Explore critical insights into immunogenicity and immunotoxicity assays for cancer therapies.
Drug Discovery News November 2024 Issue
Latest IssueVolume 20 • Issue 6 • November 2024

November 2024

November 2024 Issue

Explore this issue